Plexāā Joins JLABS EMEA
Plexāā is thrilled to announce that they have joined Johnson & Johnson’s global incubator network, JLABS, as a virtual member company of JLABS EMEA. This marks a meaningful step in Plexāā’s mission to help patients prehabilitate and precondition before surgery through the power of supraphysiological preconditioningTM which has been shown to reduce wound healing complications in proof-of-concept clinical trials.
JLABS is the largest global network of open innovation ecosystems, enabling and empowering emerging companies with the knowledge, experience, partnerships, and venture connections across a broad healthcare spectrum including pharmaceutical and medical technology sectors.
Plexāā aims to leverage virtual membership offerings, including world-class mentorship, cutting-edge resources, and invaluable industry connections, to continue developing and scaling BLOOM⁴³ and future devices.
“I’m beyond excited for our team to be among this extraordinary community as we continue in our mission of becoming standard of care and helping patients achieve a better surgical experience,” – Dr. Saahil Mehta, Founder & CEO of Plexāā.
About Plexāā
Plexāā is a pioneering UK MedTech company focused on improving surgical outcomes through innovative solutions. Their flagship device, BLOOM⁴³ enables patients to supraphysiologically precondition their skin, potentially reducing the risk of wound healing complications such as infection and skin necrosis, which affect 1 in 3 women undergoing breast surgery.
BLOOM⁴³ is the world’s first fully wearable device worn next to the skin before breast surgery. By gently warming the area to stimulate the release of Heat Shock Proteins (HSPs). These naturally occurring proteins cause the release of carbon monoxide into the tissue which vasodilates the blood vessels and improves the blood flow to the skin. This improved blood flow primes the skin to heal and has been shown to prevent wound healing complications in proof-of-concept clinical trials.
Plexāā is also exploring the application of this technology in other surgical fields, including obstetrics for C-sections, orthopedics for joint operations, and general and vascular surgery, with a commitment to improving pre-operative preparation for surgery and patient outcomes.
Media Contact: